Stock listing
Zai Lab Ltd.
- Ticker
- HKEX:9688
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
About Zai Lab Ltd.
Zai Lab Ltd. is a public company listed on the Hong Kong Stock Exchange under the ticker 9688. Zai Lab focuses on developing innovative medicines to address unmet medical needs.
Latest news from Zai Lab Ltd.
Monthly return of equity issuer on movements in securities for the month ended 30 september 2026
Oct 5, 2026
Zai Lab to Announce Second Quarter 2026 Financial Results and Recent Corporate Updates on August 6, 2026
Jul 22, 2026
Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer
Jun 8, 2026
Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a DLL3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (epNECs)
May 11, 2026